Fig. 3From: Statin use and the risk of hepatocellular carcinoma among patients with chronic hepatitis B: an emulated target trial using longitudinal nationwide population cohort dataSubgroup analysis. Adjusted for total cholesterol, LDL cholesterol, use of calcium channel blocker, aspirin, and angiotensin II receptor blocker (covariates with SMD greater than 0.1)Back to article page